$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
治疗急性髓性白血病新药恩西地平使用禁忌和用药注意事项
2025-10-19 11:44:20
Check Details
FDA批准恩西地平治疗带有IDH2突变成人复发性/难治性急性髓性白血病
2025-10-19 11:44:20
Check Details
恩西地平适用为成年患者有复发或难治性急性髓性白血病(AML)的治疗
2025-10-19 11:44:20
Check Details
恩西地平对IDH2突变急性髓性白血病患者有良好的疗效
2025-10-19 11:44:20
Check Details
施达赛对慢粒白血病的生存期
2025-10-19 11:44:20
Check Details
施达赛可用于治疗对伊马替尼耐药的患者
2025-10-19 11:44:20
Check Details
施达赛多少钱一盒?国内能买到吗?
2025-10-19 11:44:20
Check Details
施达赛治疗慢性髓细胞白血病的效果
2025-10-19 11:44:20
Check Details
苯达莫司汀是慢性淋巴细胞白血病的一线治疗药物吗?
2025-10-19 11:44:20
Check Details
施达赛2021年纳入医保后多少钱一盒?
2025-10-19 11:44:20
Check Details
白血病患者的新选择-博舒替尼
2025-10-19 11:44:20
Check Details
FDA批准苯达莫司汀用于慢性淋巴细胞白血病(CLL)的治疗
2025-10-19 11:44:20
Check Details
1
2
...
4909
4910
4911
4912
4913
4914
4915
...
10242
10243
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
2
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
3
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
4
Pralsetinib and Hypertension in NSCLC: Risks, Monitoring and Management
5
Tucatinib Overview: HER2-Positive Breast Cancer and RAS Wild-Type Colorectal Cancer Dosing, Brain Metastases Data and Safety
6
FDA Approves Durvalumab Plus Enfortumab Vedotin for Perioperative Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
7
Bepirovirsen (Hibsago) Prescribing Information: Indications, Boxed Warnings, Dose Adjustment and Monitoring
8
Avapritinib (Ayvakit) Prescribing Information: Indications, Dosage, Adverse Reactions and Safety Warnings
9
Daraxonrasib Pregnancy, Lactation and Contraception Safety
10
Afatinib Side Effects and Safety Management
11
Capmatinib for MET Exon 14 Non-Small Cell Lung Cancer
12
Ibrutinib for CLL/SLL: Not for Immediate Use at Diagnosis